Patients with severe asthma are at increased risk for a decreased quality of life, fixed airway obstruction, hospitalization, and death. Biologics may be required to reduce the disease burden. This review discusses the mechanisms, efficacy, and safety of biologics for severe asthma
PURPOSE OF REVIEW: There are multiple FDA-approved biologics to treat poorly controlled moderate-to-...
Severe asthma imposes a significant burden on patients, families and healthcare systems. Management ...
Severe asthma imposes a significant burden on patients, families and healthcare systems. Management ...
Patients with severe asthma are at increased risk for a decreased quality of life, fixed airway obst...
Biologic Therapies for Severe Asthma Patients with severe asthma are at increased risk for a decreas...
: Around 5-10% of the total asthmatic population suffer from severe or uncontrolled asthma, which is...
Abstract Severe asthma has a great impact on the quality of life (QOL) of patients and their familie...
Over the past decade, the complex pathophysiology of asthma has become better understood, helping to...
Asthma is one of the most common noncommunicable diseases; in the majority of patients it is well co...
By selectively targeting specific steps of the immune inflammation cascade, biologic drugs for sever...
Asthma is a heterogeneous disease with considerable variability noted in disease severity, patterns ...
Estimated to represent less than 5% of all asthmatic patients, children with severe asthma experienc...
Patients with severe asthma experience severe symptoms and frequent exacerbations despite intensive ...
Severe asthma is a serious disease affecting about 5-10% of asthmatic patients. Often patients with ...
Asthma is a respiratory disorder with considerable heterogeneity in aetiology, triggers, clinical ch...
PURPOSE OF REVIEW: There are multiple FDA-approved biologics to treat poorly controlled moderate-to-...
Severe asthma imposes a significant burden on patients, families and healthcare systems. Management ...
Severe asthma imposes a significant burden on patients, families and healthcare systems. Management ...
Patients with severe asthma are at increased risk for a decreased quality of life, fixed airway obst...
Biologic Therapies for Severe Asthma Patients with severe asthma are at increased risk for a decreas...
: Around 5-10% of the total asthmatic population suffer from severe or uncontrolled asthma, which is...
Abstract Severe asthma has a great impact on the quality of life (QOL) of patients and their familie...
Over the past decade, the complex pathophysiology of asthma has become better understood, helping to...
Asthma is one of the most common noncommunicable diseases; in the majority of patients it is well co...
By selectively targeting specific steps of the immune inflammation cascade, biologic drugs for sever...
Asthma is a heterogeneous disease with considerable variability noted in disease severity, patterns ...
Estimated to represent less than 5% of all asthmatic patients, children with severe asthma experienc...
Patients with severe asthma experience severe symptoms and frequent exacerbations despite intensive ...
Severe asthma is a serious disease affecting about 5-10% of asthmatic patients. Often patients with ...
Asthma is a respiratory disorder with considerable heterogeneity in aetiology, triggers, clinical ch...
PURPOSE OF REVIEW: There are multiple FDA-approved biologics to treat poorly controlled moderate-to-...
Severe asthma imposes a significant burden on patients, families and healthcare systems. Management ...
Severe asthma imposes a significant burden on patients, families and healthcare systems. Management ...
DOI
Add to ORKG